AI drug discovery
Relation and Deerfield form NewCos to develop drugs from AI-discovered targets
Relation; Deerfield Management; strategic collaboration; NewCo; AI drug discovery; Lab-in-the-Loop platform; novel therapeutics; immunology; metabolic disease; bone disease; drug targets; royalties
Models are out, molecules are in as AI drug startups sprint to the clinic
AI drug discovery; AI-designed molecules; clinical-stage AI startups; small-molecule therapeutics; biotech funding; Insilico Medicine; Recursion Pharmaceuticals; Absci; PsiThera; clinical trials
Roche Pays $55M Upfront to Manifold Bio in $2B+ Deal for AI-Guided Next-Gen Brain Shuttles
Roche; Manifold Bio; blood-brain barrier; BBB shuttles; neurological diseases; AI drug discovery; research deal; upfront payment; milestones; therapeutic payloads
Flagship Pioneering Launches Expedition Medicines to Revolutionize Small-Molecule Drug Discovery with AI
Flagship Pioneering; Expedition Medicines; AI drug discovery; small molecules; covalent binding drugs; Lila Sciences; biotech startup; generative design; executive leadership
Takeda Expands De Novo Protein Research with Second AI-Driven Collaboration with Nabla Bio
Takeda; Nabla Bio; de novo protein design; AI drug discovery; Joint Atomic Model (JAM); multi-year collaboration; protein therapeutics; antibody design; biopharmaceutical innovation
NanoPhoria Secures €83.5M Series A for Heart Failure Therapy; AstraZeneca and Algen Ink Up to $555M AI Drug Discovery Pact
NanoPhoria; Series A; heart failure; NP-MP1; nano-in-micro delivery; AstraZeneca; Algen Biotechnologies; AI drug discovery; immunology; CRISPR; gene modulation; deal value